provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content
HomeHealth ConditionsHeart Attack

What Medications Are Typically Prescribed After Having a Heart Attack (Myocardial Infarction)?

Sarah A. Samaan, MDKatie E. Golden, MD
Written by Sarah A. Samaan, MD | Reviewed by Katie E. Golden, MD
Updated on December 9, 2024

Key takeaways:

  • Heart attacks are usually caused by blood clots that form at the site of cholesterol plaques in the heart arteries. So you will likely take an antiplatelet medication to prevent another heart attack.

  • Other medications, including statins and beta blockers, can help protect your heart and reduce your risk of long-term heart conditions.

  • If you experience side effects with any of your heart medications, there are often alternative options that have similar benefits.

Access savings on related medications

Pills next to a stethoscope.
FatCamera/iStock via Getty Images Plus

Every year, over 800,000 people in the U.S. have a heart attack (myocardial infarction). And after a heart attack, at least 1 in 5 people will have another one within the next 5 years. This is a high number, especially given that heart attacks can be fatal or result in permanent heart damage.

If you recently had a heart attack, there are plenty of changes you can make to help prevent another one. And one of the most important is to take the medications that are recommended by your cardiologist. In this article, we’ll go over the common medications that you may be given after a heart attack. We’ll discuss the benefits of each one, and explain possible side effects to look out for.

Antiplatelet medications

Platelets are specialized blood cells that help to form clots. Antiplatelet medications help stop platelets from clumping together. Heart attacks are usually caused by clots that form on top of cholesterol plaques. So antiplatelet medications are critical for both treatment and prevention of heart attacks. The two kinds of antiplatelet medications used after heart attacks are aspirin and P2Y12 inhibitors.

Aspirin

Aspirin is available over the counter (OTC). If you have a heart attack, you’ll likely need to take aspirin (or another antiplatelet medication) for the rest of your life to help prevent another heart attack. Most of the time, the dose will be 81 mg (sometimes called “baby aspirin”). 

Daily aspirin is recommended for most people after a heart attack. If you can’t take it due to an allergy or another reason, you may be prescribed a daily P2Y12 inhibitor instead. For up to a year after a heart attack, your cardiologist may prescribe aspirin plus a P2Y12 inhibitor. We’ll cover combined therapy in more detail in the next section.

Common side effects of aspirin include upset stomach and heartburn. And since they help prevent your blood from clotting, aspirin and other antiplatelets may raise your risk of bleeding. 

GoodRx icon

P2Y12 inhibitors

Like aspirin, P2Y12 inhibitors work by preventing platelets from sticking together. These medications include: 

If your heart attack was treated with a stent, you’ll usually need to take both a P2Y12 inhibitor and aspirin. Most people will take both for 12 months after a heart attack. The time frame can vary depending on what kind of stent you have and your other health conditions. 

Similar to aspirin, P2Y12 inhibitors may raise your bleeding risk. But there are some important differences among the different P2Y12 inhibitors: 

  • Prasugrel and ticagrelor are usually more effective than clopidogrel. 

  • Prasugrel should usually be avoided if you’ve had a stroke in the past, if you’re over the age of 75, or if you weigh less than 60 kg (132 lbs).

  • Ticagrelor can sometimes cause shortness of breath or a slow heart rate.

Depending on your heart condition and other health issues, your cardiologist may recommend one option over the others.

Statins

Statins are medications that help lower your LDL (“bad”) cholesterol. They do this by decreasing the amount of cholesterol that your liver makes. This is important because high cholesterol is a known risk factor for heart disease. These medications also reduce inflammation in the heart arteries. That’s why they’re usually prescribed after a heart attack, even if your baseline cholesterol is in the normal range.

There are several statins available. Most of them are generic. Examples include:

Most people do well with statins. Some people will experience muscle pain when taking a statin. But a recent study found that most of the time, the muscle pain that someone experiences on a statin is not actually due to the medication. That doesn’t mean you should ignore it. There’s also a rare but serious side effect — called rhabdomyolysis — that causes muscle tissue to break down. If it’s untreated, it can result in kidney damage. 

It’s important to check in with your prescriber if you feel that you may be having side effects from your statin. A blood test will show if you have rhabdomyolysis. And if your pain seems to be related to the medication, even if the blood test is normal, you may be able to take a different statin medication. 

Statins can also cause liver damage, though this is rare. Regular blood testing, once or twice a year, will pick up any sign of liver issues.

If you aren’t able to take a statin, or if they don’t lower your cholesterol enough, you may need a second option. These medications include:

  • Ezetimibe (Zetia)

  • PCSK9 inhibitors, including alirocumab (Praluent), and evolocumab (Repatha)

  • Bempedoic acid (Nexletol)

  • Bile acid sequestrants, including Welchol and Colestipol

If your triglycerides are high, statins can help with this, too. But if they remain elevated, additional medications include:

  • Omega-3 fatty acids like Lovaza and Vascepa

  • Fibrates, including fenofibrate (Antara) and gemfibrozil (Lopid)

Beta blockers

Beta blockers help lower your heart rate and reduce the impact of stress on the heart. They can also lower your blood pressure. That’s important because high blood pressure can contribute to a heart attack. In some cases, beta blockers can also help to keep your heart rhythm regular

If your heart is weak or not pumping normally, beta blockers may lower the risk of dying after a heart attack. If you have normal heart function, then a beta blocker might be beneficial for the first year after a heart attack. Of course, everyone’s situation is a little different. Your cardiologist can help you understand if this is the right treatment for you.

Beta blockers commonly prescribed after a heart attack include: 

Since beta blockers can lower your heart rate and blood pressure, it’s important to track this at home with a home blood pressure monitor. Beta blockers may sometimes cause fatigue, dizziness, and erectile dysfunction. 

It’s important that you don’t stop taking your beta blocker suddenly. That’s because it could cause a rebound elevation of your blood pressure and heart rate. Check in with your cardiologist before making any changes. They can work with you to adjust or change your regimen.

ACE inhibitors or ARBs

Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs)  are two types of medications that work very similarly. They can help protect the heart after a heart attack. Both types of medication can lower blood pressure. And, if you have heart failure due to a weak or damaged heart muscle, they can help to strengthen your heart. 

Many times, these medications are taken along with beta blockers. ACE inhibitors and ARBs are commonly prescribed for people with other underlying conditions, like diabetes or chronic kidney disease. But ACE inhibitors and ARBs aren’t combined. You’ll either take one or the other.

Examples of ACE inhibitors include:

Examples of ARBs include 

There are a few side effects to know about:

  • ACE inhibitors and ARBs usually lower blood pressure. It’s important to check your home readings to be sure you’re staying in a normal range.

  • If you’re on an ACE inhibitor or an ARB, you’ll have periodic blood tests to make sure your kidneys are functioning well and your potassium level is normal. Although these medications are usually protective for the kidneys, they can sometimes reduce kidney function. 

  • Up to 11% of people may get a dry cough with an ACE inhibitor. That is unusual with ARBs. So if you develop a bothersome cough while taking an ACE inhibitor, an ARB is usually a better choice.

  • In rare cases, people can develop angioedema on these medications. This is a condition that can cause life-threatening swelling in the face, throat, or tongue. If that happens, get to an emergency room immediately. Angioedema can interfere with breathing, and can be fatal if not treated promptly. Angioedema is more common with ACE inhibitors, but it can also happen with ARBs.

How long do you have to take medication after having a heart attack?

You’ll likely need to take low-dose aspirin or another antiplatelet medication for life after a heart attack. That’s because aspirin and P2Y12 medications reduce the risk of a second heart attack. In fact, your risk may be three times higher if you stop taking your antiplatelet medication.

If you have a stent placed, you’ll probably need to take both aspirin and a P2Y12 inhibitor together for up to a year. The combination of the two medications will help to prevent your stent from clotting. 

Statins and other cholesterol medications are also lifelong preventive therapy. Of course, medical science keeps advancing, so there may be other options in the future.

Depending on your heart’s health, your blood pressure, and your other health conditions, you may also need to take a beta blocker, ACE inhibitor, or ARB for life. These medications can both protect and strengthen your heart.

What happens if you stop taking them?

As we mentioned above, it’s critical to stay on your antiplatelet medications after a heart attack. That includes aspirin. Your cardiologist will let you know when it’s time to change the dose or switch to a different medication. If you stop taking them in the first several months after a stent, your stent may get blocked by a blood clot. This will cause a heart attack, and can be fatal.

If you need to have any type of surgery or procedure, a healthcare professional may tell you to stop taking your aspirin for up to a week beforehand. Always check with your cardiologist before doing so. The surgeon may not be aware of your recent heart issues. Sometimes, if the procedure is elective, it may be best to delay it until you are past the first 6 to 12 months.

If you stop taking your beta blocker, ACE inhibitor, or ARB, this could affect your heart’s recovery from the heart attack. If you have high blood pressure, it’s likely that it will rise without these medications. And if you have heart failure, stopping the medications can reverse your progress and weaken your heart. That can happen even months or years later. 

If you stop your cholesterol medication, this will also raise your risk of having another heart attack in the future. That’s because your cholesterol numbers are likely to increase. You’ll also lose the anti-inflammatory effect of statins and similar cholesterol medications. 

The bottom line

After you have a heart attack, you may leave the hospital with several new prescriptions. These can include antiplatelet medications, cholesterol-lowering medications, and blood pressure pills. It’s normal to have questions and concerns about your medications. Each medication has a different role in helping your heart recover and keeping it strong. If you have side effects, your prescriber can help you find a medication that works for you. By keeping up with your medications, you’ll have the best chance at making a good recovery and staying well.

why trust our exports reliability shield

Why trust our experts?

Sarah A. Samaan, MD
Sarah Samaan, MD, FACC, FACP, FASE is a board-certified cardiologist who practiced clinical cardiology for nearly 30 years. She is a member of the American College of Cardiology, the American College of Physicians, the American Society of Nuclear Cardiology, and the American Society of Echocardiography.
Katie E. Golden, MD
Katie E. Golden, MD, is a board-certified emergency medicine physician and a medical editor at GoodRx.

References

American Heart Association. (2019). Proactive steps can reduce chances of second heart attack

American Heart Association. (2022). Understand your risks to prevent a heart attack

View All References (28)

American Heart Association. (2024). Home blood pressure monitoring

Biondi-Zoccai, G. G. L., et al. (2006). A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. European Heart Journal

Centers for Disease Control and Prevention. (2024). Heart disease facts

Cholesterol Treatment Trialists’ Collaboration. (2022). Effect of statin therapy on muscle symptoms: An individual participant data meta-analysis of large-scale, randomised, double-blind trials. The Lancet

Damman, P., et al. (2011). P2Y12 platelet inhibition in clinical practice. Journal of Thrombosis and Thrombolysis

Diamantis, E., et al. (2017). The anti-inflammatory effects of statins on coronary artery disease: An updated review of the literature. Current Cardiology Reviews

Dicpinigaitis, P. V. (2006). Angiotensin-converting enzyme inhibitor-induced cough. Chest Journal

Farzam, K., et al. (2023). Beta blockers. StatPearls

Fei, Y., et al. (2020). Efficacy and safety of newer P2Y12 inhibitors for acute coronary syndrome: A network meta-analysis. Scientific Reports

Gilstrap, L. G., et al. (2017). Initiation, continuation, or withdrawal of angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers and outcomes in patients hospitalized with heart failure with reduced ejection fraction. Journal of the American Heart Association

Haymore, B. R., et al. (2008). Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors: A meta-analysis. Annals of Allergy, Asthma, and Immunology

Huang, E. S., et al. (2012). Long term use of aspirin and the risk of gastrointestinal bleeding. The American Journal of Medicine

Joo, S. J. (2023). Beta-blocker therapy in patients with acute myocardial infarction: Not all patients need it. Acute and Critical Care

Kamran, H., et al. (2021). Oral antiplatelet therapy after acute coronary syndrome: A review. Journal of the American Medical Association

Kezerashvili, A., et al. (2012). Beta blocker use after acute myocardial infarction in the patient with normal systolic function: When is it “Ok” to discontinue? Current Cardiology Reviews

Koracevic, G., et al. (2020). Beta blocker rebound phenomenon is important, but we do not know its definition, incidence or optimal prevention strategies. Hypertension Research

Krakowiak, A., et al. (2020). Ticagrelor-related severe dyspnoea: Mechanisms, characteristic features, differential diagnosis and treatment. Clinical Medicine Insights: Case Reports

Marquis-Gravel, G., et al. (2024). Age and aspirin dosing in secondary prevention of atherosclerotic cardiovascular disease. Journal of the American Heart Association

MedlinePlus. (2022). Antiplatelet drugs – P2Y12 inhibitors

Momoniat, T., et al. (2019). ACE inhibitors and ARBs: Managing potassium and renal function. Current Drug Therapy

Park, C. S., et al. (2021). Left ventricular ejection fraction 1 year after acute myocardial infarction identifies the benefits of the long-term use of β-blockers: Analysis of data from the KAMIR-NIH registry. Circulation: Cardiovascular Interventions

Pinto, B., et al. (2020). ACEI-induced cough: A review of current evidence and its practical implications for optimal CV risk reduction. Indian Heart Journal

Silvain, J., et al. (2024). Beta-blocker interruption or continuation after myocardial infarction. The New England Journal of Medicine

Sim, H. W., et al. (2020). Beta-blockers and renin-angiotensin system inhibitors in acute myocardial infarction managed with inhospital coronary revascularization. Scientific Reports

Talha, K. M., et al. (2024). Consequences of discontinuing long-term drug treatment in patients with heart failure and reduced ejection fraction. Journal of the American College of Cardiology

Thapar, M., et al. (2013). Statins and liver injury. Gastroenterology and Hepatology

Thompson, W., et al. (2021). Statin discontinuation and cardiovascular events among older people in Denmark. Journal of the American Medical Association Network Open

Virani, S. S., et al. (2023). 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: A report of the American Heart Association/American College of Cardiology Joint Committee on clinical practice guidelines. Circulation

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

Was this page helpful?

Boost Heart Health, Not Blood Pressure

Whether you were recently diagnosed with high blood pressure, want to reduce your risk, or want to better understand your treatment options, our free 7-day guide can help.

By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.